ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bacchella, L
Right arrow Articles by Luisetti, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bacchella, L
Right arrow Articles by Luisetti, M
Eur Respir J 1996; 9: 1648-1651
Copyright © ERS Journals Ltd 1996


Original Articles

Serum type I and type III procollagen peptide levels in sarcoidosis

L Bacchella, C Tinelli, LS Gile, V Peona, C Aprile, M Gorrini, L Pasturenzi, G Cetta, and M Luisetti

Type I and type III are the most abundant collagens in the lung. The aim of our study was to compare type I and III procollagen peptides in sera of sarcoid patients. Sixty eight patients with sarcoidosis were studied (19 with newly recognized disease, 7 with relapsing disease, 15 with chronic disease, and 27 in stable remission). Thirty healthy volunteers served as controls. The levels of procollagen I and III peptides were determined by radioimmunoassay. Angiotensin-converting enzyme (ACE) level was evaluated by means of a colorimetric assay. In patients with newly recognized sarcoidosis, both serum procollagen I and III peptide levels were increased with respect to controls (p=0.0014 and p<0.00001, respectively). There was a poor correlation between levels of procollagen I and III (r=0.26), whereas there was a closer correlation between procollagen III and ACE (r=0.69). Procollagen I peptide level did not identify patients in roentgenological stage III. In conclusion, in patients with newly recognized sarcoidosis there is a significant increase in the serum level of procollagen I peptide. However, procollagen I peptide is not a marker of sarcoid patients with fibrosis, ie. stage III disease. Its clinical usefulness seems to be weaker than that of procollagen III peptide.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
T. Rampino, G. Cancarini, M. Gregorini, P. Guallini, M. Maggio, A. Ranghino, G. Soccio, and A. Dal Canton
Hepatocyte Growth Factor/Scatter Factor Released during Peritonitis Is Active on Mesothelial Cells
Am. J. Pathol., October 1, 2001; 159(4): 1275 - 1285.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. LAMMI, L. RYHÄNEN, E. LAKARI, J. RISTELI, P. PÄÄKKÖ, K. KAHLOS, S. LÄHDE, and V. KINNULA
Type III and Type I Procollagen Markers in Fibrosing Alveolitis
Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 818 - 823.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.